AzTrials
AzTrials

OpioidsWWNCT07799766

WorkWell - Preventing Prescription Opioid Misuse Among Employees Working in High Risk Industries

A study testing WorkWell in people with Opioids, run by Prevention Strategies, LLC at 2 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

WorkWell is a mobile-delivered behavioral intervention designed to prevent prescription opioid misuse and overuse among construction workers and healthcare workers. Two sequential randomized factorial optimization trials evaluated intervention lessons targeting opioid-related beliefs, norms, pain-management… Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Opioids
What is being tested?
WorkWell
Could I receive a placebo?
No, everyone receives an active treatment
How many people
759 participants
Where
2 sitesUnited States
Study dates
7 Aug 2024to 5 Jan 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Age 18 years or older Construction worker, nurse, or nursing assistant

Who cannot join

  • Under 18 years of age Not employed as a construction worker, nurse, or nursing assistant

Trial locations and contacts

2 sites in 1 country.

United States2 sites
  • Cone Health

    Greensboro, North Carolina, 27401

  • Samet Corporation

    Greensboro, North Carolina, 27409

Other trials in United States

About this study

Official title: Preventing Prescription Opioid Misuse Among Employees Working in High Risk Industries

WorkWell is a mobile-delivered behavioral intervention designed to prevent prescription opioid misuse and overuse among construction workers and healthcare workers. Two sequential randomized factorial optimization trials evaluated intervention lessons targeting opioid-related beliefs, norms, pain-management alternatives, and patient-provider communication. Participants completed assessments at baseline, immediately after the intervention, and approximately 30 days later.

Conditions
Opioids
Being tested
WorkWell

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • WorkWellBehavioural

    Mobile-delivered behavioral intervention designed to prevent prescription opioid misuse and overuse among construction workers and nurses. WorkWell includes lessons addressing opioid-related knowledge, expectancies, norms, pain management alternatives, and patient-provider communication.

Study groups in NCT07799766
Study groupRoleWhat they receive
Knowledge Lesson OnlyExperimentalParticipants received the WorkWell Knowledge lesson but did not receive the four experimentally varied lessons: Norms, Expectancies, Pain Management Alternatives, or Patient-Provider Communication.
Receives: Behavioral: WorkWell
Knowledge + NormsExperimentalParticipants received the Knowledge lesson and the Norms lesson.
Receives: Behavioral: WorkWell
Knowledge + ExpectanciesExperimentalParticipants received the Knowledge lesson and the Expectancies lesson.
Receives: Behavioral: WorkWell
Knowledge + Pain Management AlternativesExperimentalParticipants received the Knowledge lesson and the Pain Management Alternatives lesson.
Receives: Behavioral: WorkWell
Knowledge + Patient-Provider CommunicationExperimentalParticipants received the Knowledge lesson and the Patient-Provider Communication lesson.
Receives: Behavioral: WorkWell
Knowledge + Norms + ExpectanciesExperimentalParticipants received the Knowledge, Norms, and Expectancies lessons.
Receives: Behavioral: WorkWell
Knowledge + Norms + Pain ManagementExperimentalParticipants received the Knowledge, Norms, and Pain Management Alternatives lessons.
Receives: Behavioral: WorkWell
Knowledge + Norms + Patient-Provider CommunicationExperimentalParticipants received the Knowledge, Norms, and Patient-Provider Communication lessons.
Receives: Behavioral: WorkWell
Knowledge + Expectancies + Pain Management AlternativesExperimentalParticipants received the Knowledge, Expectancies, and Pain Management Alternatives lessons.
Receives: Behavioral: WorkWell
Knowledge + Expectancies + Patient-Provider CommunicationExperimentalParticipants received the Knowledge, Expectancies, and Patient-Provider Communication lessons.
Receives: Behavioral: WorkWell
Knowledge + Pain Management + Patient-Provider CommunicationExperimentalParticipants received the Knowledge, Pain Management Alternatives, and Patient-Provider Communication lessons.
Receives: Behavioral: WorkWell
Knowledge + Norms + Expectancies + Pain ManagementExperimentalParticipants received the Knowledge, Norms, Expectancies, and Pain Management Alternatives lessons.
Receives: Behavioral: WorkWell
Knowledge + Norms + Expectancies + Patient-Provider CommunicationExperimentalParticipants received the Knowledge, Norms, Expectancies, and Patient-Provider Communication lessons.
Receives: Behavioral: WorkWell
Knowledge + Norms + Pain Management Alternatives + Patient-Provider CommunicationExperimentalParticipants received the Knowledge, Norms, Pain Management Alternatives, and Patient-Provider Communication lessons.
Receives: Behavioral: WorkWell
Knowledge + Expectancies + Pain Management Alternatives + Patient-Provider CommunicationExperimentalParticipants received the Knowledge, Expectancies, Pain Management Alternatives, and Patient-Provider Communication lessons.
Receives: Behavioral: WorkWell
All WorkWell LessonsExperimentalParticipants received the Knowledge, Norms, Expectancies, Pain Management Alternatives, and Patient-Provider Communication lessons.
Receives: Behavioral: WorkWell

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Expectancies

    Prescription opioid misuse and/or overuse expectancies held by construction workers and nurses.

    Measured: Measured at pre-survey, immediate post survey, and then 30 days following post survey

  2. Normative Perceptions

    Prescription opioid misuse and/or overuse normative perceptions held by construction workers and nurses.

    Measured: Measured at pre-survey, immediate post survey, and then 30 days following post survey

  3. Behavioral Contral

    Perceived behavioral control of prescription opioid misuse and/or overuse intentions held by construction workers and nurses.

    Measured: Measured at pre-survey, immediate post survey, and then 30 days following post survey

  4. Intentions

    Intentions to misuse and/or overuse prescription opioids among construction workers and nurses.

    Measured: Measured at pre-survey, immediate post survey, and then 30 days following post survey

Secondary outcomes (3)
  1. Initiation

    Initiation of prescription opioid misuse and/or overuse among construction workers and nurses.

    Measured: Measured at pre-survey and then 30 days following post survey

  2. Opioid Misuse

    Prescription opioid misuse reported by construction workers and nurses.

    Measured: Measured at pre-survey and then 30 days following post survey

  3. Opioid Overuse

    Prescription opioid overuse reported by construction workers.

    Measured: Measured at pre-survey and then 30 days following post survey

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Sep 2026
  2. Study start7 Aug 2024
  3. Primary completion5 Jan 2026
  4. Study completion5 Jan 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Factorial
Masking
None (open label)
Enrolment
759 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07799766
Sponsor's protocol ID
R44DA050404
Other IDs
5R44DA050404-03
Acronym
WW
Status last verified
Aug 2026
First submitted
28 Aug 2026
Last updated
2 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing WorkWell in people with Opioids, run by Prevention Strategies, LLC at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 2 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Expectancies (time frame: Measured at pre-survey, immediate post survey, and then 30 days following post survey). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in